Osteoprotegerin and its ligands for regulating the osteal resorption: experimental and clinical application aspects under estrogen deficiency conditions

Cover Page


Cite item

Full Text

Abstract

Modem conceptions concerning the role of OPG-RANK-RANKL system in a local paracrinic mechanism of the regulation of osteoclastogenesis and osteal resorption processes are presented in this article. Here, results of the first clinical researches of prognostic signification of ORG determinations for estimating disruption manifestations in osteal metabolism under estrogen deficiency conditions as well as data on the OPG use as an anti-resorbable agent at the treatment of post-menopausal osteoporosis.

About the authors

S. V. Yureneva

Scientific Center for Obstetrics, Gynecology and Perinatology, Russian Academy of Medical Sciences

Author for correspondence.
Email: info@eco-vector.com

department of gynecological endocrinology, obstetrician-gynecologist, endocrinologist

Russian Federation, Moscow

References


Copyright (c) 2004 Eсо-Vector



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies